Feasibility and safety of intravenous thrombolysis for acute ischaemic stroke in Northern Greece

International Journal of Stroke

Volumn 6, Issue 1, 2011, Pages 91-92

  Rudolf, Jobst ^a   Tsivgoulis, Georgios ^b   Deretzi, Georgia ^a   Heliopoulos, Ioannis ^b   Vadikolias, Konstantinos ^b   Tsiptsios, Iakovos ^a   Piperidou, Charitomeni ^b  

^a PAPAGEORGIOU GENERAL HOSPITAL   (Greece)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ADULT; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBRAL ARTERY DISEASE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; DEATH; DRUG SAFETY; FEASIBILITY STUDY; GREECE; HEART INFARCTION; HUMAN; LETTER; MALE; NEUROLOGIC DISEASE; PHASE 3 CLINICAL TRIAL (TOPIC); PHASE 4 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; SAFETY; SIDE EFFECT; STROKE; TREATMENT OUTCOME;

AGED; BRAIN ISCHEMIA; COHORT STUDIES; FEASIBILITY STUDIES; FEMALE; FIBRINOLYTIC AGENTS; GREECE; HUMANS; INDEPENDENT LIVING; MALE; MIDDLE AGED; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 78650964357     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2010.00547.x     Document Type: Letter

References (6)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333:1581-7.
2. Wahlgren N, Ahmed N, Dávalos A et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007; 369:275-82.
3. Hacke W, Kaste M, Fieschi C et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European cooperative acute stroke study (ECASS). JAMA 1995; 274:1017-25.
4. Hacke W, Kaste M, Fieschi C et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet 1998; 352:1245-51.
5. Hacke W, Kaste M, Bluhmki E et al., ECASS Investigators Thrombolysis with alteplase 3 to 4-5 hours after acute ischemic stroke. N Engl J Med 2008; 359:1317-29.
6. Saqqur M, Tsivgoulis G, Molina CA et al., for the CLOTBUST Investigators Symptomatic intracerebral hemorrhage and recanalization after IV rt-PA: a multicenter study. Neurology 2008; 71:1304-12.